Financials

  • Market Capitalization 7.99 M
  • Employee 7
  • Founded 1999
  • CEO N/A
  • Website www.eloxxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000BGGWS3
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
4866
BRTX
BioRestorative Therapies, Inc. - Common Stock
0.35 USD-5.41%-12.50%-2.78%-79.77%8.92 M USD
4879
IMNN
Imunon, Inc. - Common Stock
2.03 USD+4.10%+14.69%-0.98%-37.54%8.53 M USD
4888
MTVA
MetaVia Inc. - Common Stock
1.55 USD-1.90%+6.90%-14.84%+138.46%8.00 M USD
4898
RNAZ
TransCode Therapeutics, Inc. - Common Stock
8.00 USD-5.21%+14.94%+55.64%-15.86%7.60 M USD